CLINICAL TRIALS PROFILE FOR POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00113685 ↗ | Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury | Completed | National Heart, Lung, and Blood Institute (NHLBI) | N/A | 2003-04-01 | The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness. |
| NCT00113685 ↗ | Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury | Completed | University of Washington | N/A | 2003-04-01 | The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness. |
| NCT00181077 ↗ | Hypertonic Saline Use in Preeclampsia | Completed | Johns Hopkins University | Phase 1 | 2003-06-01 | To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia. |
| NCT00311519 ↗ | A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects | Completed | Halozyme Therapeutics | Phase 4 | 2005-11-01 | The purpose of this research study to test the effectiveness of a study medication to increase how fast a solution called lactated Ringer's is absorbed when put under the skin subcutaneously. The medication to be studied is an enzyme called hyaluronidase, and is a human recombinant form of the enzyme. The drug company name for this medication is Hylenex. Hylenex was currently an investigational medication at the initiation of the study, but received FDA approval during the study. An investigational medication is a medication or formulation of a medication that is not approved by the United States Food and Drug Administration for use in this country but may be used in studies such as this one. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container
Condition Name
| Condition Name for Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container | |
| Intervention | Trials |
| Anesthesia | 5 |
| Post-ERCP Acute Pancreatitis | 4 |
| Cesarean Section | 4 |
| Hypotension | 4 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Condition MeSH
Clinical Trial Locations for Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container
Trials by Country
Clinical Trial Progress for Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container
Sponsor Name
